Free Trial
NYSE:AVTR

Avantor (AVTR) Stock Price, News & Analysis

$25.59
+2.77 (+12.14%)
(As of 07/26/2024 ET)
Today's Range
$24.00
$25.87
50-Day Range
$20.58
$25.59
52-Week Range
$16.63
$26.16
Volume
21.72 million shs
Average Volume
6.92 million shs
Market Capitalization
$17.38 billion
P/E Ratio
65.62
Dividend Yield
N/A
Price Target
$25.93

Avantor MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.69 Rating Score
Upside/​Downside
1.3% Upside
$25.93 Price Target
Short Interest
Healthy
3.16% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.25
Upright™ Environmental Score
News Sentiment
0.69mentions of Avantor in the last 14 days
Based on 23 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
23.00%
From $1.00 to $1.23 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.29 out of 5 stars

Medical Sector

154th out of 936 stocks

Analytical Instruments Industry

8th out of 27 stocks

AVTR stock logo

About Avantor Stock (NYSE:AVTR)

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

AVTR Stock Price History

AVTR Stock News Headlines

Avantor Q2 Profit Tops Estimates; Sales Down 2.0% On Organic Basis
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Avantor Inc. (AVTR) Q2 2024 Earnings Call Transcript
Avantor® Reports Second Quarter 2024 Results
Avantor Q2 2024 Earnings Preview
Here's what Wall Street expects from Avantor's earnings
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Avantor Inc AVTR
Avantor (AVTR) Scheduled to Post Quarterly Earnings on Friday
Avantor Sees Unusually Large Options Volume (NYSE:AVTR)
See More Headlines
Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/26/2024
Today
7/26/2024
Next Earnings (Confirmed)
7/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Fax
N/A
Employees
14,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$25.93
High Stock Price Target
$31.00
Low Stock Price Target
$22.00
Potential Upside/Downside
+1.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.69
Research Coverage
16 Analysts

Profitability

Net Income
$321.10 million
Pretax Margin
4.88%

Debt

Sales & Book Value

Annual Sales
$6.97 billion
Cash Flow
$1.91 per share
Book Value
$7.77 per share

Miscellaneous

Free Float
669,077,000
Market Cap
$17.29 billion
Optionable
Optionable
Beta
1.32
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives


AVTR Stock Analysis - Frequently Asked Questions

How have AVTR shares performed this year?

Avantor's stock was trading at $22.83 at the beginning of 2024. Since then, AVTR stock has increased by 12.1% and is now trading at $25.59.
View the best growth stocks for 2024 here
.

How were Avantor's earnings last quarter?

Avantor, Inc. (NYSE:AVTR) released its earnings results on Friday, April, 26th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.02. The business's quarterly revenue was down 5.6% compared to the same quarter last year.

When did Avantor IPO?

Avantor (AVTR) raised $3 billion in an initial public offering on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies acted as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Who are Avantor's major shareholders?

Avantor's top institutional investors include Artemis Investment Management LLP (1.19%), Van Lanschot Kempen Investment Management N.V. (0.43%), Bank of New York Mellon Corp (0.34%) and Country Trust Bank (0.28%). Insiders that own company stock include Michael Stubblefield, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Christophe Couturier, Thomas A Szlosek, Steven W Eck and Rajiv Gupta.
View institutional ownership trends
.

How do I buy shares of Avantor?

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Avantor own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Avantor investors own include Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), RTX (RTX), Alibaba Group (BABA) and CVS Health (CVS).

This page (NYSE:AVTR) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners